Ami Klein
Impact in
- Urology top 10%
- Urological Disorders and Treatments
Papers in
-
- Hormonal Regulation and Hypertension 4
- Pituitary Gland Disorders and Treatments 4
- Adrenal Hormones and Disorders 4
-
- Skin and Cellular Biology Research 6
- Co-authors
- Ruth Zemer (13 shared papers)Israel Nissenkorn (2 shared papers)Shulamit Zimlichman (6 shared papers)Gloria Rashid (2 shared papers)Amiram Fishman (3 shared papers)Marco M. Altaras (4 shared papers)Jöelle Bernheim (3 shared papers)H Joshua (3 shared papers)
In The Last Decade
Ami Klein
29 papers receiving 427 citations
Peers
Comparison fields: 5 of 77
- Urology 36
- Behavioral Neuroscience 15
- Oncology 104
- Cancer Research 52
- Endocrinology, Diabetes and Metabolism 53
Countries citing papers authored by Ami Klein
This map shows the geographic impact of Ami Klein's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ami Klein with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ami Klein more than expected).
Fields of papers citing papers by Ami Klein
This network shows the impact of papers produced by Ami Klein. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ami Klein. The network helps show where Ami Klein may publish in the future.
Co-authors
The 25 scholars most cited alongside Ami Klein, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 29 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Expression of cytokeratin 20 in urinary cytology of patients with bladder carcinoma. | 1998 | 73 |
| 2 | 1998 | 67 | |
| 3 | 1999 | 60 | |
| 4 | 2000 | 34 | |
| 5 | 1995 | 26 | |
| 6 | 1990 | 25 | |
| 7 | 2010 | 23 | |
| 8 | 1998 | 16 | |
| 9 | 2000 | 15 | |
| 10 | 1979 | 14 | |
| 11 | Indole-3-carbinol inhibits telomerase activity and gene expression in prostate cancer cell lines. | 2011 | 14 |
| 12 | 1980 | 14 | |
| 13 | 1978 | 12 | |
| 14 | 1997 | 7 | |
| 15 | 1994 | 7 | |
| 16 | 1994 | 5 | |
| 17 | 1992 | 4 | |
| 18 | 1990 | 3 | |
| 19 | 2002 | 3 | |
| 20 | 1991 | 3 |
About Ami Klein
Ami Klein is a scholar working on Endocrinology, Diabetes and Metabolism, Cell Biology, Molecular Biology, Genetics and Surgery, having authored 29 papers that have together received 439 indexed citations. Recurring topics across this work include Skin and Cellular Biology Research (6 papers), Chronic Lymphocytic Leukemia Research (6 papers), Hormonal Regulation and Hypertension (4 papers), Pituitary Gland Disorders and Treatments (4 papers), Adrenal Hormones and Disorders (4 papers), Urinary and Genital Oncology Studies (3 papers), Gastrointestinal disorders and treatments (3 papers) and Eosinophilic Disorders and Syndromes (3 papers). The work is most often cited by research in Urology (36 citations), Behavioral Neuroscience (15 citations), Oncology (104 citations), Cancer Research (52 citations) and Endocrinology, Diabetes and Metabolism (53 citations). Ami Klein has collaborated with scholars based in Israel, Canada and France. Frequent co-authors include Ruth Zemer, Israel Nissenkorn, Shulamit Zimlichman, Gloria Rashid, Amiram Fishman, Marco M. Altaras, Jöelle Bernheim, H Joshua, J. Shapira and B. H. Novis. Their work appears in journals such as Cancer, Gynecologic Oncology, JNCI Journal of the National Cancer Institute, Metabolism and Biochemistry and Cell Biology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.